Cancer Drug Design and Discovery (Hardcover, 2nd edition)


"Cancer Drug Design and Discovery, Second Edition" is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under development. By highlighting some of the general principles involved in taking molecules through basic science to clinical development, this book offers a complete and authoritative reference on the design and discovery of anticancer drugs for translational scientists and clinicians involved in cancer research.
Provides a clinical perspective on the development of new molecularly targeted anticancer agents with the latest and most promising chemotherapeutic approachesOffers a broad view of where the field is going, what tools drug discovery is using to produce new agents and how they are evaluated in the laboratory and clinicFeatures 6 new chapters devoted to advances in technology and successful anticancer therapies, such as cancer genomics and personalized medicine, DNA-targeted agents, B-Raf inhibitors and moreEach chapter includes extensive references to the primary and review literature, as well as to relevant web-based sources"


R2,658
List Price R2,762

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles26580
Mobicred@R249pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days


Toggle WishListAdd to wish list
Review this Item

Product Description

"Cancer Drug Design and Discovery, Second Edition" is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under development. By highlighting some of the general principles involved in taking molecules through basic science to clinical development, this book offers a complete and authoritative reference on the design and discovery of anticancer drugs for translational scientists and clinicians involved in cancer research.
Provides a clinical perspective on the development of new molecularly targeted anticancer agents with the latest and most promising chemotherapeutic approachesOffers a broad view of where the field is going, what tools drug discovery is using to produce new agents and how they are evaluated in the laboratory and clinicFeatures 6 new chapters devoted to advances in technology and successful anticancer therapies, such as cancer genomics and personalized medicine, DNA-targeted agents, B-Raf inhibitors and moreEach chapter includes extensive references to the primary and review literature, as well as to relevant web-based sources"

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Academic Press Inc

Country of origin

United States

Release date

December 2013

Availability

Expected to ship within 12 - 17 working days

Editors

Dimensions

235 x 191 x 38mm (L x W x T)

Format

Hardcover

Pages

640

Edition

2nd edition

ISBN-13

978-0-12-396521-9

Barcode

9780123965219

Categories

LSN

0-12-396521-7



Trending On Loot